Study guide

7.2 Extraoperative Functional Brain Mapping & Cortical Stimulation

ABRET Certified Long Term Monitoring Technologist CLTM

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pre-Study Preparation & Clinical Indications

1.1 Clinical Indications for Long-Term Monitoring 1.2 Patient History, Clinical Assessment & Neurological Evaluation 1.3 Recording Strategy, Protocol Planning & Patient Communication

2 Chapter 2: Electrodes, Montages & Technical Setup

2.1 Electrode Selection, Application & Scalp Integrity 2.2 True and Modified Montages for LTM 2.3 Instrument Settings, Calibration & Differential Amplification 2.4 Signal Integrity, Impedance Monitoring & Artifact Troubleshooting

3 Chapter 3: Seizure Classification, Semiology & Clinical Events

3.1 ILAE 2017 Seizure Classification Framework 3.2 Seizure Semiology & Ictal Phenotypes 3.3 Differentiating Epileptic vs Non-Epileptic Events 3.4 Event Button Workflow, Clinical Testing & Ictal Observation

4 Chapter 4: EEG Waveform Identification & Interictal Discharges

4.1 Normal Variants and Benign Epileptiform Patterns 4.2 Interictal Epileptiform Discharges (IEDs) 4.3 Electrographic and Electroclinical Seizure Patterns

5 Chapter 5: ICU Continuous EEG & Critical Care Monitoring

5.1 ACNS Standardized Critical Care Terminology 5.2 Non-Convulsive Status Epilepticus (NCSE) & Salzburg Criteria 5.3 Coma Patterns, Burst Suppression & Prognostication 5.4 Quantitative EEG (qEEG) Trends & ICU Trending Tools

6 Chapter 6: Age-Specific Monitoring: Neonatal & Pediatric LTM

6.1 Neonatal EEG & Continuous Monitoring 6.2 Pediatric Epilepsy Syndromes in the EMU 6.3 Pediatric Technical Considerations & Behavioral Strategies

7 Chapter 7: Invasive Intracranial Monitoring & Functional Mapping

7.1 Intracranial Recording Modalities (Grids, Strips, SEEG) 7.2 Extraoperative Functional Brain Mapping & Cortical Stimulation 7.3 Somatosensory Evoked Potentials (SEPs) & Central Sulcus Localization

8 Chapter 8: Provocative Testing & In-Study Interventions

8.1 Activation Procedures in LTM (HV, Photic, Sleep Deprivation) 8.2 Medication Withdrawal & Provocation Protocols 8.3 Emergency Escalation & Status Epilepticus Management

9 Chapter 9: Post-Study Procedures, Technical Reporting & Localization

9.1 Technical Summary & Technologist Reporting 9.2 Data Review, Reformatting & Montage Re-montaging 9.3 Localization Techniques & Dipole Principles 9.4 Study Completion, Electrode Removal & Infection Prevention

10 Chapter 10: Data & Equipment Management

10.1 Video-EEG Synchronization & Audio-Visual Systems 10.2 Data Pruning, Clipping & Archiving 10.3 Network Infrastructure, Server Systems & Hardware Maintenance

11 Chapter 11: Ethics, Patient Safety & Professional Standards

11.1 Patient Safety Protocols & Fall Prevention in the EMU 11.2 Regulatory Compliance: HIPAA, HITECH & Video Privacy 11.3 CPT and ICD-10 Coding for LTM Services 11.4 ABRET Code of Ethics & Professional Practice Standards

7.2 Extraoperative Functional Brain Mapping & Cortical Stimulation

Key Takeaways Explain This Topic AI

Functional mapping is patient-, anatomy-, task-, electrode-, and protocol-specific; the surgical team—not the technologist—determines resection boundaries.

Before every stimulation train, reconcile the patient-specific implant map, contact pair, montage, stimulator settings, task, and emergency plan using a verbal read-back.

A negative mapping site is negative only for the tested function and conditions; it does not prove that the cortex has no essential role.

Stop stimulation immediately for afterdischarges, a clinical seizure, or an unexpected response, preserve the record, and follow the physician/facility rescue protocol.

Mapping documentation includes contacts, orientation, pulse parameters, task, baseline accuracy, observed response, afterdischarges, interventions, and recovery.

Last updated: August 2026

7.2 Extraoperative Functional Brain Mapping & Cortical Stimulation

Extraoperative Cortical Electrical Stimulation Mapping (CESM) represents the definitive clinical neurophysiological technique for identifying and demarcating eloquent cortex —cerebral regions whose surgical resection or structural disruption would result in an irreversible, disabling neurological deficit (such as hemiplegia, dense hemianesthesia, expressive Broca aphasia, receptive Wernicke aphasia, or homonymous hemianopia). While non-invasive functional modalities (functional MRI [fMRI], magnetoencephalography [MEG], and navigated transcranial magnetic stimulation [nTMS]) guide presurgical planning, direct electrical stimulation mapping remains the universally accepted clinical gold standard for establishing surgical resection margins in drug-resistant epilepsy.

For the CLTM technologist, participating in extraoperative functional mapping in the Epilepsy Monitoring Unit (EMU) demands an in-depth mastery of electrical stimulation physics, constant-current delivery parameters, live electrocorticography (ECoG) surveillance for Afterdischarges (ADs), behavioral testing administration, and rapid clinical management of stimulation-induced seizures.

1. Clinical Objective and Team Roles

Functional mapping identifies cortex or subcortical pathways whose stimulation changes motor, sensory, language, visual, or other behavior. The surgeon and neurophysiologist integrate these positive and negative mapping sites with anatomy, imaging, seizure-onset data, and patient-specific risk. There is no universal 10 mm resection margin that the technologist applies independently; a safe boundary depends on the function tested, stimulation method, anatomy, subcortical pathways, surgical approach, and the treating team’s plan.

The technologist verifies the patient, implant map, requested contact pair, stimulator connection, recording montage, emergency equipment, and the exact task to be performed. The physician controls the clinical mapping plan and stimulation limits. The technologist operates within the delegated protocol, monitors the EEG/ECoG, administers standardized tasks, annotates each trial, and reports observed responses without declaring whether tissue may be resected.

2. Extraoperative and Intraoperative Mapping

Extraoperative mapping in the EMU permits repeated testing while the patient is awake and medically stable. It can examine multiple contact pairs and complex language tasks, but implanted leads and longer observation introduce infection, hemorrhage, and spontaneous-seizure risks. Intraoperative mapping provides direct access during surgery and immediate surgical correlation, but anesthesia, time, exposure, and patient participation constrain testing. Both settings require a current patient-specific map and explicit team communication.

3. Stimulation Parameters and Safety

Electrical stimulation is defined by current or voltage, pulse width, frequency, train duration, polarity, and contact geometry. Charge per phase and charge density matter because the same current can have different tissue effects with different contact areas and pulse widths. Subdural and SEEG stimulation protocols therefore use different ranges and escalation steps. Use only the ordered, facility-validated protocol and the stimulator/electrode manufacturer’s limits; do not import a memorized current maximum from another electrode type.

Before each train, perform a contact-pair read-back and confirm baseline EEG plus the patient’s readiness. Increase stimulation only as directed. Mark the exact start/end, parameters, task, response, afterdischarge threshold, and any clinical symptom. Repeat positive findings when the protocol permits so the team can distinguish reproducible functional effects from pain, anxiety, spontaneous behavior, or chance error.

4. Functional Responses

Motor: involuntary movement, tonic contraction, speech arrest caused by motor activation, or negative motor phenomena. Record body part, side, latency, duration, and whether the response is reproducible.

Sensory: tingling, numbness, pain, temperature, proprioceptive, or other reported sensation. Use neutral questions so the patient is not cued.

Language: naming, repetition, reading, comprehension, fluency, and spontaneous speech. Distinguish true language disruption from facial motor activation, pain, inattention, baseline error, or afterdischarges.

Visual: positive phenomena such as flashes or negative phenomena such as a field deficit. Record the patient’s report and test conditions.

Memory and higher cognition: use standardized stimuli and scoring when ordered; avoid interpreting a single error without baseline performance and repeat trials.

A “negative” site is only negative for the task, stimulus intensity, and conditions actually tested. It is not proof that the cortex lacks all essential function.

5. Language Mapping Workflow

Establish baseline naming and reading before stimulation. Present items at a consistent pace and randomize sham/no-stimulation trials if the protocol uses them. During each train, document whether the patient stopped speaking, produced phonemic or semantic errors, failed to comprehend, showed facial contraction, or simply missed an item already difficult at baseline. Preserve audio/video and the stimulation artifact so the interpreting team can correlate timing.

6. Afterdischarges and Stimulation-Induced Seizures

Afterdischarges are rhythmic or repetitive epileptiform activity that follows stimulation and may remain local, propagate, or evolve into a clinical seizure. The technologist watches the stimulated and neighboring contacts in a montage that permits rapid detection. If afterdischarges or an unexpected clinical response appears:

Stop stimulation immediately.

Announce and annotate the contact pair, parameters, onset, spread, duration, and behavior.

Continue recording and assess the patient under the team protocol.

Follow the physician/facility rescue plan. A clinician may order a validated intervention, including a different stimulation maneuver or cold irrigation in an operative setting; it is not a universal technologist-delivered volume or solution.

Do not resume until the responsible physician authorizes the next step and adjusts the plan.

7. Documentation and Quality Control

The mapping record must allow another qualified clinician to reconstruct every trial. Include contact labels and orientation, reference/montage, stimulator and electrode type, pulse parameters, task, baseline accuracy, response, afterdischarges, clinical seizure, rescue action, and recovery. Photograph or preserve the approved map according to policy and reconcile labels at shift handoff.

Common errors include testing the wrong contact pair, reversing orientation, failing to distinguish afterdischarge-related impairment from direct functional disruption, leading the patient’s response, changing several variables at once, and declaring an untested site safe. A deliberate read-back, one-variable-at-a-time escalation, objective task scoring, and complete synchronized recording prevent these failures.